Personal CFO Solutions’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240K | Sell |
|
|||||
|
2025
Q1 | $202K | Sell |
|
|||||
|
2024
Q4 | $224K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $205K | Sell |
|
|||||
|
2024
Q1 | $237K | Sell |
|
|||||
|
2023
Q4 | $402K | Buy |
|
|||||
|
2023
Q3 | $267K | Buy |
|
|||||
|
2023
Q2 | $306K | Sell |
|
|||||
|
2023
Q1 | $242K | Buy |
|
|||||
|
2022
Q4 | $205K | Sell |
|
|||||
|
2022
Q3 | $267K | Hold |
|
|||||
|
2022
Q2 | $230K | Buy |
|
|||||
|
2022
Q1 | $384K | Buy |
|
|||||
|
2021
Q4 | $347K | Sell |
|
|||||
|
2021
Q3 | $465K | Buy |
|
|||||
|
2021
Q2 | $615K | Hold |
|
|||||
|
2021
Q1 | $650K | Buy |
|
|||||
|
2020
Q4 | $1.17M | Hold |
|
|||||
|
2020
Q3 | $1K | Buy |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2020
Q1 | $748K | Buy |
|
|||||
|
2019
Q4 | $411K | Buy |
|